Advisors for the Food and Drug Administration say that Genentech's Avastin cancer drug should not be approved for expanded use in breast-cancer patients.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
